← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-10-13

Drug application

FDA Application #

ANDA217736

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

Mesalamine

Active ingredients

MESALAMINE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

First approval

2026-10-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown